WO2005100240A1 - Dnaの脱アミノ化のための組成物及びメチル化dnaの検出方法 - Google Patents
Dnaの脱アミノ化のための組成物及びメチル化dnaの検出方法 Download PDFInfo
- Publication number
- WO2005100240A1 WO2005100240A1 PCT/JP2004/017782 JP2004017782W WO2005100240A1 WO 2005100240 A1 WO2005100240 A1 WO 2005100240A1 JP 2004017782 W JP2004017782 W JP 2004017782W WO 2005100240 A1 WO2005100240 A1 WO 2005100240A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna
- sulfite
- deamination
- cytosine
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
- C01D5/00—Sulfates or sulfites of sodium, potassium or alkali metals in general
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B17/00—Sulfur; Compounds thereof
- C01B17/62—Methods of preparing sulfites in general
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01C—AMMONIA; CYANOGEN; COMPOUNDS THEREOF
- C01C1/00—Ammonia; Compounds thereof
- C01C1/22—Sulfites of ammonium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
Definitions
- the present invention relates to a composition for deamination of DNA and a method for detecting DNA.
- the present invention relates to a composition for deamination of DNA and a method for deamination of DNA. Furthermore, the present invention relates to a method for detecting methylidani DNA in a sample.
- 5-methylcytosine is the only physiologically modified base present in the eukaryotic genome, and it is also known that abnormalities in DNA methylidation cause genetic diseases and cancer. Therefore, detection of the methylated state of cytosine having a specific nucleotide sequence in the genome is particularly important.
- 5-methylcytosine forms a complementary base pair with guanine like cytosine, and it is extremely difficult to detect it by sequencing or PCR as it is.
- the most frequently used method for solving this problem is a method in which genomic DNA and sulfite are reacted to deaminate cytosine, and then converted to peracyl by alkaline hydrolysis.
- 5-Methylcytosine has very low reactivity with this reagent (see, for example, Hayatsu et al., Biochemistry, Vol. 9, p. 2858-2865 (1970)). Therefore, if a nucleotide sequence is determined after such processing, cytosine is determined to be thymine, and only the position of 5-methylcytosine is determined to be cytosine, so that the position of 5-methylcytosine can be identified. (See, for example, Formmer et al., Proc. Natl. Acad. Sci. USA, Vol. 89, p. 1827-1831 (1992)).
- the reaction condition of DNA and sulfite is generally 50 ° C in a 4.9 M sodium bisulfite solution (pH 5) at 12 to 16 hours (for example, Eads Et al., Methods in Molecular Biology, Vol. 200, p. 71-85 (2002)).
- pH 5 sodium bisulfite solution
- such a long-term reaction has been one of the causes of the inability to quickly detect cytosine.
- a main object of the present invention is to rapidly perform a deamination reaction of DNA and to prepare a methylamine derivative in a sample.
- An object of the present invention is to provide a method for detecting DNA in a short time. More specifically, an object of the present invention is to provide a method for quickly performing a deamination reaction of cytosine and detecting methylidazocytosine in a sample in a short time.
- the present inventors have conducted intensive studies to solve the above-mentioned problems. As a result, the reaction of DNA with a sulfite solution having a high bisulfite concentration allows the deamination of cytosine to proceed in an extremely short time. The present inventors have further studied, and completed the present invention.
- the present invention relates to the following sulfite composition, a method for deaminating DNA, a method for detecting methylated DNA, and a kit for deamination of DNA or detection of methylated DNA.
- Item 1 A sulfite composition having a sulfite concentration of more than 6.2M.
- the present invention relates to a sulfite composition for deamination of DNA having a sulfite concentration of more than 6.2M or for detection of methylated DNA.
- the present invention relates to the use of a sulfite composition having a sulfite concentration of more than 6.2 M for deamination of DNA or detection of methylated DNA.
- Item 2 The sulfite composition according to Item 1, having a sulfurous acid concentration of more than 6.2M and 10M or less.
- Item 3 The sulfite composition according to Item 1 or 2, wherein the pH is from 5.0 to 5.6.
- Item 4 The sulfite composition according to any one of Items 13 to 13, containing two or more sulfites.
- Item 5 The sulfite composition according to any one of Items 14 to 14, comprising two or more sulfites selected from the group consisting of an ammonium salt and a sodium salt of sulfite.
- Item 6 Including ammonium sulfite, ammonium bisulfite and sodium bisulfite Item 6.
- Item 7 A method for deaminating DNA comprising the following steps:
- the sulfite composition in the step (1) is the sulfite composition according to any one of Items 16 to 16.
- Item 8 The method for deaminating DNA according to Item 7, comprising the following step (0) before step (1):
- Item 9 The DNA deamination method according to any one of Items 7 to 8, wherein the DNA in the step (1) is a DNA comprising cytosine.
- Item 10 The method for deaminating DNA according to any one of Items 7 to 9, which is a sulfite composition having a sulfite concentration of more than 6.2 M and not more than 10 M in the step (1).
- Item 11 The DNA deamination method according to any one of Items 7 to 10, wherein the step (1) is a step of treating at a pH range of about 5 to 5.6.
- Item 12 The method for deaminating DNA according to Item 711, wherein the step (1) is a step of treating at a temperature of about 60 to 95 ° C. for about 5 to 60 minutes.
- Item 13 A method for detecting methylated DNA, comprising the following steps:
- step (a) is a step of subjecting to a deamination treatment by the method described in any one of Items 7 to 12.
- step (a) is a DNA comprising cytosine
- step (b) is a step of detecting methylated cytosine in the sample obtained in (a). Methyli dani DNA detection method.
- Item 15 The step (b), wherein the step of detecting 1S nucleotide sequence, DNA chip or restriction enzyme, is a step of detecting the methylidazocytosine in the sample, wherein the methylidanicytosine is detected in the sample. DNA detection method.
- step (b) comprises (i) means for identifying the locations of cytosine and thymine by DNA sequencing after amplification of the DNA in the sample by PCR, and (ii) After amplifying DNA by PCR, a probe that hybridizes to DNA when cytosine changes to thymine and a probe that hybridizes to DNA when cytosine does not change to thymine are immobilized.
- Item 16 At least one primer capable of amplifying nucleic acid when cytosine in the sample DNA is converted to peracil and at least one primer capable of amplifying nucleic acid when cytosine is not converted to peracil in step (b)
- Item 17 A kit for deamination of DNA, comprising the sulfite composition according to Item 1.
- kits for deamination of DNA comprising the sulfite composition according to any one of Items 116.
- the kit further comprises a DNA detection means.
- a kit for deamination of DNA further comprising a primer for amplification of DNA.
- Item 18 A kit for detecting methylated DNA comprising the sulfite composition according to Item 1.
- the present invention relates to a kit for detecting methyl sulfonate DNA, comprising the sulfite composition according to any one of Items 116.
- the kit for detecting methylated DNA further comprises a DNA detecting means.
- a kit for detecting methylated DNA further comprising a primer for amplifying DNA.
- One aspect of the present invention is a sulfite composition that exhibits high sulfite concentrations.
- Sulfurous acid in the present invention includes H SO, HSO-, SO-I and the like represented by a chemical formula.
- the sulfite concentration in the sulfite composition of the present invention is greater than 6.2M, preferably 8M or more. Further, it is preferably 10M or less. If the concentration is too low, the rate of deamination of DNA tends to decrease. On the other hand, if the concentration is too high, crystals are likely to precipitate.
- the pH of the sulfite composition of the present invention is preferably substantially the same as the optimum pH for the DNA deamination reaction. Therefore, the pH range of the sulfite composition of the present invention is preferably about 4.0 to 6.0, and more preferably about 5.0 to 5.6.
- the most preferred embodiment of the sulfite composition of the present invention is a case where the sulfite concentration is 8M or more and 10M or less and the pH is 5.0-5.6.
- the sulfite composition of the present invention having such a high sulfite concentration contains two or more sulfites! /.
- Examples of the type of sulfite include a sodium salt, an ammonium salt, and a potassium salt of sulfurous acid.
- NaHSO sodium bisulfite
- Na SO sodium sulfite
- sulfites selected from the group consisting of sodium sulfite and ammonium sulfite for reasons of solubility and pH adjustment.
- ammonium bisulfite ammonium sulfite
- sodium bisulfite sodium bisulfite
- the method for preparing the sulfite composition of the present invention is not particularly limited! In the case of a combination of ammonium, ammonium sulfite and sodium bisulfite, add the powder of sodium bisulfite and ammonium sulfite to the solution of ammonium bisulfite for about 5 to 40 minutes. , More preferably about 10-20 minutes, 50-95 ° C, preferably
- the sulfite composition of the present invention is suitably used for deamination of DNA or detection of methylated DNA.
- One embodiment of the present invention is a method for deaminating DNA.
- the method for deaminating DNA of the present invention comprises the steps of (1) treating a sample containing single-stranded DNA with the sulfite composition of the present invention, and (2) And a step of subjecting the treated sample to an alkali treatment.
- a step of denaturing the double-stranded DNA in the sample into single-stranded DNA may be further included before the step (1).
- a step of cutting the DNA with a restriction enzyme to fragment the DNA may be added before the denaturing step.
- Methods for denaturing double-stranded DNA into single-stranded DNA include, for example, heat treatment, alkali treatment and the like.
- the condition of the heat treatment is not particularly limited.
- the heat treatment is performed at about 95-100 ° C. for about 5 to 10 minutes.
- the conditions of the alkali treatment are not particularly limited.
- the treatment is performed at about 30 ° C. to 42 ° C. for about 20 to 60 minutes with 0.2 N or more alkali.
- a method of using about 0.3N sodium hydroxide and treating at about 30 to 37 ° C. for about 30 minutes is preferable.
- a sulfite composition having a sulfite concentration of more than 6.2M, preferably 8M or more, and 10M or less. If the concentration is too low, the rate of the deamination reaction will decrease. On the other hand, if the concentration is too high, crystals tend to precipitate.
- the treatment of the sample with the sulfite composition is preferably performed in a pH range of about 5.0 to 5.6. If the pH is too low or too high, the deamination rate decreases.
- the temperature of the treatment is preferably about 60 to 95 ° C, more preferably about 70 ° C and about 90 ° C. If the temperature is too low, sulfite will precipitate and the reaction will not proceed easily. If the temperature is too high However, DNA degradation may progress rapidly, which may hinder subsequent analysis.
- the processing time is preferably about 5 minutes and about 60 minutes. If the time is too short, the deamination will be insufficient. On the other hand, if the length is too long, sample damage such as DNA degradation tends to occur.
- the step (1) tends to proceed faster as the concentration of sulfurous acid is higher. Therefore, in the step (1), it is preferable to avoid injecting unnecessary solutions other than the sample and the sulfite composition as much as possible.
- the alkali treatment in the step (2) is not particularly limited as long as the sulfite group bound to the nucleic acid can be eliminated.
- sodium hydroxide, potassium hydroxide, ammonia, Z, or Tris may be added to a sample to adjust the pH to 9.0 or more, and the treatment may be performed for about 10 to 120 minutes.
- the type of the sample to be subjected to the present invention is not particularly limited, and can be applied to various cells and tissues including blood, cancer cells, cultured cells, and the like.
- the type of DNA is not limited, and may be applied to, for example, plasmid DNA, genomic DNA, and the like.
- the origin of DNA is not particularly limited, and may be applied to, for example, humans, various animals including mice, yeast, bacteria, and the like.
- the DNA deamination method of the present invention is suitably used particularly for deamination of DNA containing cytosine. Specifically, (1) a step of treating a sample containing single-stranded DNA containing cytosine with the sulfite composition of the present invention, and (2) a sample treated in (1). Can be used as a method for deaminating DNA comprising a step of converting cytosine to peracil by treating the same with alkali.
- One aspect of the present invention is a method for detecting methylated DNA.
- the method for detecting methylated DNA of the present invention includes the following steps.
- the step (a) is a step of deaminating DNA according to the DNA deamination method of the present invention.
- the sulfite concentration of the sulfite composition is preferably at least 8M It is. Also, it is preferably 10M or less.
- the treatment with the sulfurous acid composition is preferably performed at a pH range of about 5-5.6.
- the processing temperature is preferably 60-95 ° C, more preferably 70-90 ° C.
- the processing time is preferably about 10-60 minutes.
- a treatment for denaturing double-stranded DNA in the sample into single-stranded DNA may be further performed. Furthermore, when treating high-molecular-weight DNA, for example, genomic DNA, a step of cutting the DNA with a restriction enzyme and fragmenting it appropriately before the step of denaturation may be added.
- the detection method of the present invention is suitably used particularly for detection of methylated DNA cytosine among methylated DNAs. Specifically, (a) a sample containing single-stranded DNA containing cytosine is treated with the sulfite composition of the present invention, and then alkali-treated to deaminate the DNA, thereby obtaining cytosine in the DNA. Is converted to peracyl, and (b) a method comprising the step of detecting methyl idocytosine in the sample treated in (a) is obtained.
- the detection of methylidyne cytosine can be performed, for example, by base sequence determination, DNA chip or means using a restriction enzyme.
- the means using base sequence determination is (i) means for identifying the location of cytosine and thymine by base sequence determination after amplifying DNA in a sample by PCR.
- Means using a DNA chip include (ii) a probe that hybridizes to DNA when cytosine changes to thymine after amplifying DNA in the sample by PCR and cytosine does not change to thymine! ⁇ ⁇ In this case, it is a means for identifying cytosine and thymine using a DNA chip on which a probe to be hybridized is immobilized.
- Means for using restriction enzymes include (iii) using a restriction enzyme that cuts DNA and / or a restriction enzyme that does not cut when cytosine changes to thymine after amplification of DNA in the sample by PCR. This is a means for determining cytosine and thymine based on the presence or absence of DNA cleavage.
- step (b) at least one primer capable of amplifying nucleic acid when cytosine in the sample DNA is converted into peracil, and nucleic acid amplification when cytosine is not converted into peracil.
- the sample may be subjected to an amplification reaction using at least one of the possible primers, and the detection of methylidyl cytosine may be performed using a means for determining cytosine and thymine based on the presence or absence of amplification.
- a method via a DNA amplification method such as PCR is preferred!
- One embodiment of the present invention is a kit for deamination of DNA or a kit for detection of methylated DNA.
- the kit of the present invention is characterized by containing the above-mentioned sulfite composition of the present invention.
- the kit of the present invention can further include appropriate detection means for detecting deamination or methylated DNA of DNA, DNA purification means, labeling means, reagents, and the like, as appropriate.
- detection means for detecting deamination or methylated DNA of DNA DNA purification means, labeling means, reagents, and the like, as appropriate.
- a primer for amplifying DNA that can be used for PCR or the like can be included.
- Examples of the detection means include various primers, probes, restriction enzymes, fluorescent dyes, Z, and various media.
- the kit of the present invention can be particularly preferably used for performing the above-described DNA deamination method and methylated DNA detection method of the present invention.
- the DNA deamination treatment can be performed in a short time.
- deamination of DNA requires a long time of about 12 to 16 hours, and it has been difficult to rapidly detect methylated DNA.
- the deamination of DNA can be performed in a short time, and the detection of methylated DNA can be performed quickly.
- cytosine it is possible to convert cytosine to peracyl in a short time, and it is possible to rapidly detect methylidani cytosine.
- the present invention can be used for various techniques such as acquisition of genetic information and development of DNA-related techniques. For example, abnormalities in methylated DNA have been reported to be associated with various diseases such as cancer.However, rapid detection of methylated DNA according to the present invention has greatly improved diagnosis and genetic testing. Be more efficient.
- the present invention is also useful as a research tool for methylated DNA.
- the present invention greatly contributes to the promotion of the life science industry including medical treatment and the bio-related industry.
- FIG. 1 is a drawing showing the deamination rate of a sample treated with a sulfite composition in terms of the residual amount of cytosine.
- References are for 2 'deoxycytidine treated with 9 M sodium bisulfite sodium ammonia solution at 70 ° C.
- ⁇ indicates the case where 2'-deoxycytidine was treated with a 5.3 M sodium bisulfite solution at 70 ° C.
- ⁇ indicates the case where 5-methyl-2,1-deoxycytidine was treated with 9M sodium bisulfite-ammonium solution at 70 ° C.
- ⁇ indicates the case where 5-methyl-2'-deoxycytidine was treated with 9M sodium bisulfite ammpodium solution at 90 ° C.
- FIG. 2 is a drawing showing the pH dependence of a DNA deamination reaction.
- FIG. 3 is a drawing showing the results of analyzing a salmon testis DNA sample by HPLC.
- FIG. 3a shows the analysis result of the sample treated with the sulfite composition of the present invention
- FIG. 3b shows the analysis result of the untreated sample.
- C represents 2′-deoxycytidine.
- U represents 2'-deoxyperidine.
- mC represents 5-methyl-2'-deoxycytidine.
- G represents 2'-deoxyguanosine.
- T represents thymidine.
- A represents 2'-deoxyadenosine.
- FIG. 4 is a drawing relating to analysis of CDH1 gene in MCF-7 cells by sulfite treatment.
- FIG. 4 (A) shows the amplified genomic region.
- FIG. 4 (B) shows the sequence of the amplified region.
- Bold letters indicate CpG dinucleotides.
- FIG. 4 (C) shows the results of PCR amplification when sulphite-treated genomic DNA was serially diluted.
- a is the one treated by the conventional method (using a sulphite composition with a 3.6M sulfurous acid concentration at 55 ° C for 20 hours).
- b is the one obtained by treating the sulfite composition of the present invention at 90 ° C. for 20 minutes.
- FIG. 4 (D) shows the results of nucleotide sequence analysis of the plasmid clone. Each row represents an individual plasmid clone. ⁇ and gins indicate thymine and cytosine, respectively. The dot circle at position 2 counts because this position is a heterozygote in MCF-7 cells! / ⁇ ! The arrow indicates the position of cytosine in the CpG nucleotide.
- FIG. 5 is a drawing relating to analysis of RASSF1A gene in MCF-7 cells by sulfite treatment.
- FIG. 5 (A) shows the amplified genomic region.
- FIG. 5 (B) shows the sequence of the amplified region.
- Bold letters indicate CpG dinucleotides.
- the complementary strand was used as type ⁇
- Fig. 5 (C) shows the results of PCR amplification when sulphite-treated genomic DNA was serially diluted.
- a is the result of treatment by the conventional method (using a sulfite composition having a sulfur concentration of 3.6 M at 55 ° C for 20 hours).
- FIG. 5 (D) shows the results of nucleotide sequence analysis of the plasmid clone. Each row represents an individual plasmid clone. ⁇ and ⁇ refer to thymine and cytosine, respectively. The arrow indicates the position of cytosine in the CpG nucleotide.
- Sulfurous acid concentration is measured by utilizing the fact that sulfur dioxide is generated from sulfite in a hydrochloric acid solution, and the absorbance (A) at 276 nm changes depending on the amount of generated sulfur dioxide.
- a cuvette (lxlx4 cm, manufactured by Hitachi High-Technologies Corporation) for measuring absorbance was charged with 3 ml of 0.IN hydrochloric acid (manufactured by Wako Pure Chemical Industries, Ltd.).
- a sulfite solution 301 diluted with distilled water was poured into the cuvette, covered with a thin film, stirred three times, and then mixed with a spectrophotometer (Model U, manufactured by Hitachi Keiki Kiki Service Co., Ltd.). -2800) was used to measure the absorbance at 276 nm.
- Table 1 shows the measured values and the concentrations calculated therefrom.
- the calculated value represents the sulfite concentration (M (mol / l)) calculated from the mass and molecular weight of each dissolved sulfite.
- the measured value represents the sulfite concentration (M) measured according to the method 0-A.
- the solubility at 70 ° C was 5.9M for sodium bisulfite, 2.1M for sodium sulfite, and 4.3M for ammonium sulfite monohydrate.
- the obtained solution is also referred to as a mixed solution of sodium hydrogen sulfite and ammonium.
- Solutions were prepared by dissolving 2,1-deoxycytidine or 5-methyl-2, -deoxycytidine (manufactured by Sigma) in distilled water to a concentration of 0.2 M each.
- the absorbance of the unreacted sample (2'-deoxycytidine solution having the same concentration after treatment with a sulfite solution) was 0.8.
- the absorbance of only the 9 M sodium bisulfite ammodemium solution was 0.05.
- the absorbance of the unreacted sample was set to 100%, and the deamination reaction product was quantified based on the decrease in the absorbance of the reaction sample.
- FIG. 1 shows the results of the deamination reaction.
- the results were 1 minute or less, 5 minutes and 17 minutes, respectively.
- the reaction time was 5 minutes and the temperature was 60 ° C.
- the optimum pH was 5.0 to 5.6.
- Salmon testis DNA (manufactured by Sigma) was dissolved in sterile water to a concentration of 1.6 mg / ml. This solution
- a Sephadex G-50 column ( ⁇ 15 ⁇ 40 mm, Bio-Rad Econo Pack 10, manufactured by Bio-Rad) was prepared by buffering the reaction solution with TE buffer (10 mM Tris-HCl (pH 8), ImM EDTA). And a desalting operation was performed.
- the DNA fraction was collected by UV monitoring, and 2.5 times the volume of cold ethanol (manufactured by Wako Pure Chemical Industries, Ltd.) of the collected DNA fraction, and 1/10 the volume of 3M sodium acetate (pH 5 .2) was dried to precipitate DNA.
- DNA precipitated by centrifugation was separated and recovered, and then dissolved in 100 ⁇ l of sterile water.
- DNA was decomposed into nucleosides by adding 0.2 units of phosphodiesterase and 2 units of alkaline phosphatase (promega) and treating them for 90 minutes. After the decomposition reaction product was separated from proteins and unreacted substances by an ethanol precipitation operation, the solution was suction-dried. After dissolving in 30 ⁇ 1 sterile water, the amount of nucleoside was measured by the HPLC analysis method described in 1D above.
- FIG. 3 shows a chart of the HPLC analysis, and Table 2 shows the ratio of each nucleoside.
- C represents 2'-deoxycytidine.
- U represents 2'-deoxyperidine.
- mC represents 5-methyl-2'-deoxycytidine.
- G represents 2'-deoxyguanosine.
- T represents thymidine.
- A represents 2'-deoxyadenosine.
- the deamination rate of cytosine in cytoplasmic genomic DNA (conversion rate from cytosine to peracyl) after treatment in a 9M ammiodium sulfite solution at 90 ° C for 10 minutes was 99.6%.
- the conversion of 5-methylcytosine was less than 10%. Conversion of still other bases was unrecognizable.
- the reaction times at which similar deamination rates were obtained at 70 ° C. and 37 ° C. were 16 minutes and 170 minutes, respectively.
- the DNA was purified using Wizard DNA Clean-UP system (Promega) according to the instruction manual, and dissolved in 90 ⁇ l of sterilized water. The 1 12 ⁇ sodium hydroxide solution was added thereto and treated at 37 ° C. for 10 minutes. DNA was collected by ethanol precipitation using 10 g of yeast tRNA (manufactured by Sigma) as a carrier, and dissolved in 100 ⁇ l of ⁇ buffer (10 mM Tris-HCl (pH 8.0), ImM EDTA).
- PCR was performed in a 50 ⁇ l reaction system using AmpliTaq DNA polymerase (manufactured by Applied Biosystems) using the two primers shown in SEQ ID NOs: 1 and 2 in the sequence listing. Was done.
- the cycle conditions were 95 ° C, 3 minutes later, 95 ° C, 30 seconds ⁇ 57 ° C, 30 seconds ⁇ 70 ° C, 3 minutes, 30 cycles, and other conditions were in accordance with the instruction manual.
- 11 samples were analyzed by agarose gel electrophoresis to confirm the amount of amplification.
- CpG islands of the CDH1 gene and RASSF1A gene have been reported to be non-methylated or methylated, respectively (Koizume et al., Nucleic Acids Res., 30, 4770-4780, 2002 and Dammann et al., Cancer Res., 61, 3105-1109, 2001). Therefore, it was examined whether or not these CpG islands could reproduce the methylated state after treatment with the 9M sulfite composition.
- Genomic DNA obtained from human breast cancer MCF-7 cells was digested with the restriction endonuclease TSP509I. After phenol-chloroform treatment and ethanol precipitation treatment, and after drying, dissolve the DNA in 451 sterile water, add 51N 3N sodium hydroxide solution, and treat at 37 ° C for 30 minutes. Denatured to strand DNA. Add 565 ⁇ l (90 ° C) and 5451 (70 ° C) of 10M sulfite composition to single-stranded denatured DNA solution, and treat at 90 ° C for 20 minutes or at 70 ° C for 40 minutes did .
- DNA was purified using Wizard DNA Clean-UP system (manufactured by Promega) according to the instruction manual, and dissolved in 901 sterile water. 11 1 The 2N sodium hydroxide solution of sodium hydroxide was added and treated at 37 ° C. for 10 minutes. DNA was recovered by ethanol precipitation using 10 / z g of yeast tRNA (manufactured by Sigma) as a carrier and dissolved in 161 TE buffer (10 mM Tris-HCl (pH 7.5), ImM EDTA).
- DNA was recovered by ethanol precipitation using 10 g of yeast tRNA (manufactured by Sigma) as a carrier, and dissolved in 16 ⁇ l of ⁇ buffer (10 mM Tris-HCl (pH 7.5), ImM EDTA). It was.
- the MCF-7 DNA treated with the sulfite composition was serially diluted with TE (10 mM Tris-HCl (pH 7.5) / lmM EDTA (pH 8.0)) containing 1.25 mg / ml yeast tRNA. After incubating at 95 ° C for 3 minutes, the Ampli Taq DNA polymerase Stoffel fragment was digested, and the first stage amplification was performed at 95 ° C for 30 seconds, 55 ° C for 30 seconds, and 72 ° C for 30 seconds. 20 cycles were performed under the conditions. The reaction was performed according to Koizume et al.'S literature (Nucleic Acids Res., 30, pp.
- Type II DNA was used in an amount of 500 ng, 50 ng, 5 ng or 500 pg. 3 or the sequences shown in SEQ ID NO: 4 (CDH1-L1) and SEQ ID NO: 5 (CDH1-R1) in the Sequence Listing were used.
- Semi-nested PCR was performed under the same conditions as described above except that 30 cycles were performed using the sequences shown in SEQ ID NO: 6 (CDH1-L2) and SEQ ID NO: 7 (CDH1-R2) in the column list.
- CDH1 CDH1-L1 ATTTAGTGGAATTAGAATAGTGTAGGTTTT (791-820, L34545)
- CDH1-R1 CTACAACTCCAAAAACCCATAACTAAC (1139-1165, L34545)
- CDH1-L2 cggaattcTTAGTAATTTTAGGTTAGAGGG (837-858, L34545)
- CDH1-R2 cgggatcCTACAACTCCAAAAACCCATAACTAAC (1139-1165, L34545)
- RASSF1A RASSF1A-L1 cggaattcGTTTTGGTAGTTTAATGAGTTTAGGTTTTTTTT (18092-18122, AC002481)
- RASSF1A-R1 ACCCTCTTCCTCTAACACAATAAAACTAACC (17741-17771, AC002481)
- RASSF1A-R2 cgggatCCCCACAATCCCTACACCCAAAT (17918-17940, AC002481)
- PCR analysis was performed in the same manner as in 4-B above, except for the following points.
- the first step PCR primer the sequences shown in Table 3 or SEQ ID NO: 9 (RASSF1A-L1) and SEQ ID NO: 10 (RASSF1A-R1) in the sequence listing were used.
- the PCR primers the sequences shown in Table 3 or SEQ ID NO: 9 (RASSF1A-L1) and SEQ ID NO: 11 (RASSF1A-R2) in the sequence listing were used.
- the analyzed strands contained 48 cytosines in the amplified region, 16 of which were at CpG sites.
- cytosines at non-CpG sites were converted to peracil in all 12 plasmid clones analyzed. In contrast, most cytosines at CpG sites were unconverted. Similar results were obtained when MCF-7 DNA treated with a 9M sulfite composition at 90 ° C. for 20 minutes or 70 ° C. for 40 minutes was used as type I.
- the conversion process from cytosine to peracil required a long time of about 12 to 16 hours.
- the conversion of cytosine to peracil is also performed in a short time, and It was found that the detection of cytosine methylethylani could also be performed quickly.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/593,130 US20080070240A2 (en) | 2004-04-08 | 2004-11-30 | Composition for deaminating dna and method of detecting methylated dna |
| JP2006519303A JPWO2005100240A1 (ja) | 2004-04-08 | 2004-11-30 | Dnaの脱アミノ化のための組成物及びメチル化dnaの検出方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004-114476 | 2004-04-08 | ||
| JP2004114476 | 2004-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2005100240A1 true WO2005100240A1 (ja) | 2005-10-27 |
Family
ID=35149901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2004/017782 Ceased WO2005100240A1 (ja) | 2004-04-08 | 2004-11-30 | Dnaの脱アミノ化のための組成物及びメチル化dnaの検出方法 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20080070240A2 (ja) |
| JP (1) | JPWO2005100240A1 (ja) |
| WO (1) | WO2005100240A1 (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12082795B2 (en) | 2009-06-22 | 2024-09-10 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
| EP4460577A4 (en) * | 2022-01-06 | 2025-12-31 | Univ Chicago | METHODS AND COMPOSITIONS FOR THE RAPID DETECTION AND ANALYSIS OF CYTOSINE METHYLATION OF RNA AND DNA |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006034264A2 (en) * | 2004-09-21 | 2006-03-30 | Applera Corporation | Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis |
| JP2008136404A (ja) * | 2006-11-30 | 2008-06-19 | Sysmex Corp | Dnaメチル化検出における非メチル化シトシン変換処理後のdna量の確認方法 |
| US9315853B2 (en) | 2012-01-30 | 2016-04-19 | Exact Sciences Corporation | Modification of DNA on magnetic beads |
| CN111269963B (zh) * | 2019-12-31 | 2021-07-13 | 广东凯普生物科技股份有限公司 | 一步法核酸提取转化试剂盒及其使用方法 |
| CN117535377A (zh) * | 2023-06-02 | 2024-02-09 | 柏锘(上海)医疗科技有限公司 | 转化胞嘧啶的方法及其用途 |
| WO2025250766A1 (en) * | 2024-05-29 | 2025-12-04 | The University Of Chicago | Methods and compositions for rapid detection and analysis of rna and dna modifications |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004000128A (ja) * | 2002-04-05 | 2004-01-08 | Japan Science & Technology Corp | 造血器腫瘍細胞検出方法および造血器腫瘍細胞検出キット |
| JP2004500892A (ja) * | 2000-06-19 | 2004-01-15 | エピゲノミクス アーゲー | シトシン−メチル化の検出方法 |
| JP2004089195A (ja) * | 2002-08-29 | 2004-03-25 | F Hoffmann La Roche Ag | 亜硫酸水素塩処理のための改善された方法 |
| EP1443052A1 (en) * | 2003-01-29 | 2004-08-04 | Roche Diagnostics GmbH | Improved method for bisulfite treatment of nucleic acid |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3909408A (en) * | 1971-02-27 | 1975-09-30 | Asahi Chemical Ind | Process for treating aldehydes |
| US3971734A (en) * | 1973-08-28 | 1976-07-27 | Nl Industries, Inc. | Sulfite compositions, aqueous sulfite solutions and method of decreasing their rate of oxidation |
| US3966880A (en) * | 1975-06-17 | 1976-06-29 | American Chemical & Refining Company Inc. | Method for producing alkali metal gold sulfite |
| DE10112515B4 (de) * | 2001-03-09 | 2004-02-12 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität |
| DE10201138B4 (de) * | 2002-01-08 | 2005-03-10 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungsmustern durch exponentielle Ligation hybridisierter Sondenoligonukleotide (MLA) |
| DE602004009038T3 (de) * | 2003-01-29 | 2015-06-25 | Roche Diagnostics Gmbh | Verbessertes Verfahren zur Behandlung durch Bisulfit |
-
2004
- 2004-11-30 JP JP2006519303A patent/JPWO2005100240A1/ja active Pending
- 2004-11-30 US US10/593,130 patent/US20080070240A2/en not_active Abandoned
- 2004-11-30 WO PCT/JP2004/017782 patent/WO2005100240A1/ja not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004500892A (ja) * | 2000-06-19 | 2004-01-15 | エピゲノミクス アーゲー | シトシン−メチル化の検出方法 |
| JP2004000128A (ja) * | 2002-04-05 | 2004-01-08 | Japan Science & Technology Corp | 造血器腫瘍細胞検出方法および造血器腫瘍細胞検出キット |
| JP2004089195A (ja) * | 2002-08-29 | 2004-03-25 | F Hoffmann La Roche Ag | 亜硫酸水素塩処理のための改善された方法 |
| EP1443052A1 (en) * | 2003-01-29 | 2004-08-04 | Roche Diagnostics GmbH | Improved method for bisulfite treatment of nucleic acid |
Non-Patent Citations (2)
| Title |
|---|
| HAYATSU H. ET AL: "DNA methylation analysis: Speedup of bisulfite-mediated deamination of cytosine in the genomic sequencing procedure.", PROC JPN ACAD., vol. 80, 2004, pages 189 - 194, XP002987141 * |
| RAIZIS A.M. ET AL: "A bisulfite method of 5-methylcytosine mapping that minimizes template degradation.", ANAL BIOCHEM., vol. 226, 1995, pages 161 - 166, XP002241348 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12082795B2 (en) | 2009-06-22 | 2024-09-10 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
| EP4460577A4 (en) * | 2022-01-06 | 2025-12-31 | Univ Chicago | METHODS AND COMPOSITIONS FOR THE RAPID DETECTION AND ANALYSIS OF CYTOSINE METHYLATION OF RNA AND DNA |
Also Published As
| Publication number | Publication date |
|---|---|
| US20080070240A2 (en) | 2008-03-20 |
| JPWO2005100240A1 (ja) | 2008-03-06 |
| US20070178466A1 (en) | 2007-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7535611B2 (ja) | ライブラリー調製方法ならびにそのための組成物および使用 | |
| EP2825645B1 (en) | Methods and compositions for discrimination between cytosine and modifications thereof, and for methylome analysis | |
| EP3837379B1 (en) | Method of nucleic acid enrichment using site-specific nucleases followed by capture | |
| Shiraishi et al. | High-speed conversion of cytosine to uracil in bisulfite genomic sequencing analysis of DNA methylation | |
| EP1590362B1 (en) | Improved method for bisulfite treatment | |
| EP4090766B1 (en) | Methods of targeted sequencing | |
| CN110628880B (zh) | 一种同步使用信使rna与基因组dna模板检测基因变异的方法 | |
| JP2007509629A (ja) | 二本鎖dnaの切断による複合核酸分析 | |
| US20220333186A1 (en) | Method and system for targeted nucleic acid sequencing | |
| CA3187549A1 (en) | Compositions and methods for nucleic acid analysis | |
| CN114262735B (zh) | 用于表征多核苷酸的衔接体及其用途 | |
| WO2000043531A9 (en) | Methods and kits for characterizing gc-rich nucleic acid sequences | |
| US7501240B2 (en) | Method for bisulfite treatment | |
| WO2000043531A2 (en) | Methods and kits for characterizing gc-rich nucleic acid sequences | |
| CN114854826A (zh) | 序列、包含序列的接头及其用途 | |
| CN110295231A (zh) | 通过选择性等位基因富集或消耗用低深度测序检测和定量稀有变体 | |
| US20200063194A1 (en) | Comprehensive single molecule enhanced detection of modified cytosines | |
| EP2698437A1 (en) | Method and kit for detecting 5-hydroxymethylcytosine in nucleic acids | |
| WO2005100240A1 (ja) | Dnaの脱アミノ化のための組成物及びメチル化dnaの検出方法 | |
| WO2020094457A1 (en) | Liquid sample workflow for nanopore sequencing | |
| US20080206772A1 (en) | Sample treatment solution and reagent kit for preparing sample for detecting dna methylation | |
| Clark et al. | Bisulphite genomic sequencing of methylated cytosines | |
| CN116888276A (zh) | 一种用于高通量靶向测序的多重pcr文库构建方法 | |
| US20230122979A1 (en) | Methods of sample normalization | |
| CN117187221A (zh) | 人工改造脱氨酶辅助的dna中5-羟甲基胞嘧啶修饰单碱基分辨率定位分析方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 2006519303 Country of ref document: JP |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 10593130 Country of ref document: US Ref document number: 2007178466 Country of ref document: US |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
| 122 | Ep: pct application non-entry in european phase | ||
| WWP | Wipo information: published in national office |
Ref document number: 10593130 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 10593130 Country of ref document: US |